Sep 16, 2016 - 1. We have a question related to offering a discount if an event is delivered via webinar. Can you please advise if the Agency is planning to ...
Jan 16, 2018 - framework of Regulation (EC) No 1049/2001 on access to documents because they are subject to on- going procedures for ... Co-rapp: C. Muñoz. For decision: Need for oral explanation. For adoption: Scientific overview and list of outsta
Feb 22, 2017 - route over that period i.e. only 7 âswitchesâ applications were submitted centrally. For the vast majority ... Head of Business Data and Analytics.
Mar 15, 2018 - (Article 5(12) (b) of Regulation (EC) No 141/2000 of the European Parliament and of the Council). When a designated orphan medicinal product receives a positive opinion for marketing authorisation from EMA's Committee for Medicinal Pro
Feb 27, 2018 - Tazemetostat for treatment of follicular lymphoma, Quintiles Ireland Limited. 2. Opinions adopted at the first COMP discussion: â¢. Docosahexaenoic acid ethyl ester for treatment of sickle cell disease, TurnKey PharmaConsulting. Irela
Feb 8, 2018 - 30 Churchill Place â Canary Wharf â London E14 5EU â United Kingdom. Telephone +44 (0)20 3660 6000 ... This document provides current information related to the volume and evaluation of marketing authorisation and ... The purpose
Mar 5, 2018 - it includes the INN (active moiety only, with no information on salt, ester or derivative) and therapeutic area. This list only includes information for medicines whose applications have been validated at the time the report was compile
Jul 12, 2018 - An agency of the European Union ... This list only includes information for medicines whose applications have been validated at the time the.
Jun 22, 2018 - An agency of the European Union. Telephone +44 (0)20 ... Selumetinib for treatment of neurofibromatosis type 1, AstraZeneca AB;. â¢. Synthetic ...
Jun 15, 2017 - relocation of the Agency, it might be necessary to hold extraordinary meetings solely dedicated to. Brexit-related topics. In such cases, the ...
Apr 28, 2017 - 2. The United Kingdom will then become a 'third country'. 3. Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties. In view of the considerable uncertainties, in parti
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.
Sep 26, 2016 - 13 October 2016, 9:00 â 12:00, room 7/B, via teleconference. Health and safety information. In accordance with the Agency's health and safety ...
Sep 26, 2016 - Send a question via our website www.ema.europa.eu/contact ... safety and emergency information and procedures prior to the start of the ...
Mar 8, 2018 - Treatment of uterine fibroids. Haematology. New medicines authorised. ⢠Adynovi (rurioctocog alfa pegol). Treatment and prevention of bleeding in patients with haemophilia A. New information on authorised medicines. ⢠Feraccru (ferr
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...
Treatment of cystine crystal deposits in the eye. New information on authorised medicines. Lucentis (ranibizumab) - change in indication. Treatment of visual ...
